Blue Trust Inc’s AYTU BioPharma AYTU Stock Holding History

Blue Trust Inc’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-278	Closed	–	–	2482
2023 Q3	$0	Hold	278	–	–	﹤0.01%	2027
2023 Q2	$1K	Sell	278 -5,301	-95%	-$10.4K	﹤0.01%	1803
2023 Q1	$1K	Buy	5,579 +5,300	+1,900%	+$15.5K	﹤0.01%	2105
2022 Q4	$1K	Hold	279	–	–	﹤0.01%	2010
2022 Q3	$4K	Hold	279	–	–	﹤0.01%	1603
2022 Q2	$6K	Buy	+279	New	+$3.57K	﹤0.01%	1365

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blue Trust Inc's AYTU Position: Q4 2023 in Review

Blue Trust Inc sold out of AYTU BioPharma (AYTU) in Q4 2023, closing a stake of 278 shares.

Blue Trust Inc first reported a position in AYTU in Q2 2022 and held it in 6 quarters. The position peaked at $6K in Q2 2022. 22 funds tracked by Wall St. Rank hold AYTU as of Q4 2023.

Blue Trust Inc reported no remaining AYTU BioPharma position as of Q4 2023 after selling out during the quarter.
Blue Trust Inc sold 278 AYTU BioPharma shares in Q4 2023.
Blue Trust Inc first reported a position in AYTU BioPharma in Q2 2022 and held it in 6 quarters.
Blue Trust Inc's AYTU BioPharma position peaked at $6K in Q2 2022.
22 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2023.

Based on Blue Trust Inc's 13F filing for Q4 2023, filed 18 Jan 2024.